Kaiser Permanente Ventures

Kaiser Permanente Ventures (KP Ventures) is a leading venture capital firm dedicated to investing in innovative healthcare solutions. Founded in 1998, KP Ventures has over $500 million in assets under management and focuses on areas such as health information technology, digital health, medical devices, diagnostics, and precision medicine. KP Ventures recently closed its fifth fund at $141 million, which includes contributions from Kaiser Permanente as well as other strategic investors like Tufts Health Plan, Henry Ford Health System, and Highmark Ventures. The firm's investment strategy aims to support companies that address significant unmet needs in the healthcare system, particularly those that align with Kaiser Permanente's mission of providing high-quality, affordable, and accessible care​. Some notable companies in their portfolio include iRhythm, Health Catalyst, and Omada Health. KP Ventures leverages its deep connections with Kaiser Permanente and other healthcare leaders to help its portfolio companies navigate and thrive in the complex healthcare landscape. The team at KP Ventures comprises experienced professionals like Cindy Vanderlinde-Kopper, Amy Belt Raimundo, and co-founders Chris Grant and Chris Stenzel, who bring extensive expertise in healthcare and venture investing.